BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23118962)

  • 1. Molecular basis for modulation of the p53 target selectivity by KLF4.
    Brandt T; Townsley FM; Teufel DP; Freund SM; Veprintsev DB
    PLoS One; 2012; 7(10):e48252. PubMed ID: 23118962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha.
    Akaogi K; Nakajima Y; Ito I; Kawasaki S; Oie SH; Murayama A; Kimura K; Yanagisawa J
    Oncogene; 2009 Aug; 28(32):2894-902. PubMed ID: 19503094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of the Klf4 DNA-binding domain links to self-renewal and macrophage differentiation.
    Schuetz A; Nana D; Rose C; Zocher G; Milanovic M; Koenigsmann J; Blasig R; Heinemann U; Carstanjen D
    Cell Mol Life Sci; 2011 Sep; 68(18):3121-31. PubMed ID: 21290164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage.
    Yoon HS; Chen X; Yang VW
    J Biol Chem; 2003 Jan; 278(4):2101-5. PubMed ID: 12427745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2).
    Tidow H; Veprintsev DB; Freund SM; Fersht AR
    J Biol Chem; 2006 Oct; 281(43):32526-33. PubMed ID: 16887812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of the p53-KLF4-CEBPA Axis in Acute Myeloid Leukemia.
    Seipel K; Marques MT; Bozzini MA; Meinken C; Mueller BU; Pabst T
    Clin Cancer Res; 2016 Feb; 22(3):746-56. PubMed ID: 26408402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative binding of p53 to its promoter and DNA recognition elements.
    Weinberg RL; Veprintsev DB; Bycroft M; Fersht AR
    J Mol Biol; 2005 May; 348(3):589-96. PubMed ID: 15826656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for Kruppel-like factor 4 in determining the outcome of p53 response to DNA damage.
    Zhou Q; Hong Y; Zhan Q; Shen Y; Liu Z
    Cancer Res; 2009 Nov; 69(21):8284-92. PubMed ID: 19826046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilization.
    Xi G; Shen X; Wai C; White MF; Clemmons DR
    J Biol Chem; 2019 Feb; 294(7):2407-2421. PubMed ID: 30578299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.
    Kim MK; Jeon BN; Koh DI; Kim KS; Park SY; Yun CO; Hur MW
    J Biol Chem; 2013 Mar; 288(10):7053-64. PubMed ID: 23329847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krüppel-like factor 4 exhibits antiapoptotic activity following gamma-radiation-induced DNA damage.
    Ghaleb AM; Katz JP; Kaestner KH; Du JX; Yang VW
    Oncogene; 2007 Apr; 26(16):2365-73. PubMed ID: 17016435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.
    Zhang W; Geiman DE; Shields JM; Dang DT; Mahatan CS; Kaestner KH; Biggs JR; Kraft AS; Yang VW
    J Biol Chem; 2000 Jun; 275(24):18391-8. PubMed ID: 10749849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective transcription of p53 target genes by zinc finger-p53 DNA binding domain chimeras.
    Falke D; Fisher MH; Juliano RL
    Biochim Biophys Acta; 2004 Nov; 1681(1):15-27. PubMed ID: 15566940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene.
    Koh DI; Choi WI; Jeon BN; Lee CE; Yun CO; Hur MW
    J Biol Chem; 2009 Jul; 284(30):19856-66. PubMed ID: 19491398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global re-wiring of p53 transcription regulation by the hepatitis B virus X protein.
    Chan C; Thurnherr T; Wang J; Gallart-Palau X; Sze SK; Rozen S; Lee CG
    Mol Oncol; 2016 Oct; 10(8):1183-95. PubMed ID: 27302019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krüppel-like factor 4 interacts with p300 to activate mitofusin 2 gene expression induced by all-trans retinoic acid in VSMCs.
    Zhang R; Han M; Zheng B; Li YJ; Shu YN; Wen JK
    Acta Pharmacol Sin; 2010 Oct; 31(10):1293-302. PubMed ID: 20711222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for Klf4 recognition of methylated DNA.
    Liu Y; Olanrewaju YO; Zheng Y; Hashimoto H; Blumenthal RM; Zhang X; Cheng X
    Nucleic Acids Res; 2014 Apr; 42(8):4859-67. PubMed ID: 24520114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative transcriptional activation by Klf4, Meis2, and Pbx1.
    Bjerke GA; Hyman-Walsh C; Wotton D
    Mol Cell Biol; 2011 Sep; 31(18):3723-33. PubMed ID: 21746878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation by p53: one protein, many possibilities.
    Laptenko O; Prives C
    Cell Death Differ; 2006 Jun; 13(6):951-61. PubMed ID: 16575405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-Like Factor 4 and Its Activator APTO-253 Induce NOXA-Mediated, p53-Independent Apoptosis in Triple-Negative Breast Cancer Cells.
    Nakajima W; Miyazaki K; Asano Y; Kubota S; Tanaka N
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.